Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

28.4%

40 terminated/withdrawn out of 141 trials

Success Rate

69.9%

-16.6% vs industry average

Late-Stage Pipeline

4%

6 trials in Phase 3/4

Results Transparency

61%

57 of 93 completed trials have results

Key Signals

2 recruiting57 with results27 terminated13 withdrawn

Enrollment Performance

Analytics

Phase 1
45(34.9%)
N/A
34(26.4%)
Phase 2
29(22.5%)
Early Phase 1
15(11.6%)
Phase 3
6(4.7%)
129Total
Phase 1(45)
N/A(34)
Phase 2(29)
Early Phase 1(15)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (141)

Showing 20 of 141 trials
NCT06626516Phase 1Recruiting

Tebentafusp-tebn With LDT in Metastatic UM

Role: collaborator

NCT01760655Phase 2Completed

Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies

Role: lead

NCT03076255Not ApplicableCompleted

Using a Head and Neck Maskless Immobilization Device For Patients With Intracranial Tumors

Role: lead

NCT03580499Not ApplicableCompleted

Vitamin B6 in Reducing Hot Flashes in Participants With Prostate Cancer Undergoing Antiandrogen Therapy

Role: lead

NCT02315157Phase 1Withdrawn

Bendamustine Hydrochloride in Treating Patients With Previously Treated Multiple Myeloma

Role: lead

NCT07184775Not ApplicableRecruiting

CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes

Role: collaborator

NCT01326468Not ApplicableWithdrawn

Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer

Role: lead

NCT03712904Phase 2Terminated

Stereotactic Body Radiation Therapy and Aflibercept in Treating Patients With Uveal Melanoma

Role: lead

NCT02467738Early Phase 1Completed

Surgical Resection and Intraoperative Cesium-131 Brachytherapy for Head and Neck Cancer

Role: lead

NCT01655836Phase 1Active Not Recruiting

High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer

Role: lead

NCT03712878Phase 2Completed

2-Step Approach to Stem Cell Transplant in Treating Participants With Hematological Malignancies

Role: lead

NCT03489252Not ApplicableCompleted

Remote Activity Monitored by Fitbit Charge 3 in Investigating Daily Step and Sleep Data in Participants With Head and Neck Cancer Undergoing Radiation Therapy

Role: lead

NCT03039413Early Phase 1Completed

Copper Cu-64 TP3805 PET/CT in Imaging Patients With Urothelial Cancer Undergoing Surgery or Biopsy

Role: lead

NCT01356628Phase 2Completed

A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer

Role: lead

NCT01819233Not ApplicableCompleted

Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy

Role: lead

NCT01184898Not ApplicableCompleted

Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML)

Role: lead

NCT01350258Phase 1Terminated

Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps

Role: lead

NCT03162887Not ApplicableCompleted

Educational Module and Decision Counseling Program in Increasing Mammography Screening Rates in Formerly Homeless Women With Serious Mental Illness

Role: lead

NCT02555176Not ApplicableCompleted

Low-Carbohydrate Normocaloric Diet in Patients With Head and Neck Carcinoma (HNC)

Role: lead

NCT03578224Early Phase 1Completed

Contrast-Enhanced Ultrasound Identification of Sentinel Nodes in Esophageal Cancer

Role: lead